SCHEMBL460020

SCHEMBL460020

CCCCCCCCc1cccc2[nH]nnc12

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.42
KCNH2 Q12809 2/20 0.42
BID P55957 3/20 0.40
MCL1 Q07820 3/20 0.40
BCL2L1 Q07817 2/20 0.40
BAK1 Q16611 2/20 0.40
KAT8 Q9H7Z6 2/20 0.40
PPARA Q07869 2/20 0.40
PPARG P37231 1/20 0.40
EP300 Q09472 1/20 0.40
KAT2A Q92830 1/20 0.40
KAT2B Q92831 1/20 0.40
KAT5 Q92993 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
PTGS2 P35354 2/20 0.39
ALOX5 P09917 1/20 0.39
TLR8 Q9NR97 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8664501 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL28043410 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL7549695 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL28479318 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL27635841 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL8633987 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL29743329 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL8406883 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
SCHEMBL461413 1.00 LIPG (0.42) LIPGKCNH2BIDMCL1BCL2L1
Ammonia Solution, Strong SCHEMBL28384089 0.98 LIPG (0.41) LIPGKCNH2BIDMCL1BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107193188-B Resist stripping liquid composition and method for stripping resist using same 东友精细化工有限公司 2021-07-30 CN claimed
US-20130277825-A1 Method for Preventing Corrosion of Copper-Aluminum Intermetallic Compounds TEXAS INSTRUMENTS INCORPORATED (US) 2013-10-24 US claimed
EP-0397454-A1 Higher alkylbenzotriazoles as copper and copper alloy corrosion inhibitors CALGON CORPORATION (US) 1990-11-14 EP claimed
CN-122095059-A Contains high content of C9Lubricant composition of di-substituted diphenylamine antioxidant 2026-05-26 CN disclosed
WO-2026099357-A1 LUBRICATING OIL COMPOSITIONS INFINEUM INTERNATIONAL LIMITED (GB) 2026-05-15 WO disclosed
US-20260132352-A1 LUBRICATING OIL COMPOSITIONS INFINEUM INTERNATIONAL LTD (GB) 2026-05-14 US disclosed
WO-2026087620-A1 LUBRICANT COMPOSITIONS CONTAINING HIGH C9 DISUBSTITUTED DIPHENYLAMINE ANTIOXIDANT CONTENT INFINEUM INTERNATIONAL LIMITED (GB) 2026-04-30 WO disclosed
EP-4596662-B1 AMINE CONTAINING POLYMERS AND LUBRICANT COMPOSITIONS INCLUDING SUCH POLYMERS AND METHODS OF USING THEREOF INFINEUM INT LTD (GB) 2026-04-29 EP disclosed
US-20260109910-A1 Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content and Low Mono- and Tri-substituted Diphenylamine Antioxidant Content INFINEUM INTERNATTIONAL LTD (GB) 2026-04-23 US disclosed
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 US disclosed
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 US disclosed
EP-0258021-B1 METHOD OF INHIBITING THE CORROSION OF COPPER IN AQUEOUS SYSTEMS BETZ EUROPE, INC. (US) 1989-10-18 EP disclosed
EP-0258021-A1 Method of inhibiting the corrosion of copper in aqueous systems BETZ EUROPE, INC. (US) 1988-03-02 EP disclosed
EP-0141839-B1 PHOSPHORUS-CONTAINING METAL SALTS/SULFURIZED PHENATE COMPOSITIONS/AROMATIC SUBSTITUTED TRIAZOLES, CONCENTRATES, AND FUNCTIONAL FLUIDS CONTAINING SAME The Lubrizol Corporation (US) 1987-07-29 EP disclosed
US-4663063-A OIL AND FUEL ADDITIVES THE LUBRIZOL CORPORATION (US) 1987-05-05 US disclosed
EP-0203969-A1 ALKYL PHENOL AND AMINO COMPOUND COMPOSITIONS AND TWO-CYCLE ENGINE OILS AND FUELS CONTAINING SAME. LUBRIZOL CORP (US) 1986-12-10 EP disclosed
WO-1986003220-A1 ALKYL PHENOL AND AMINO COMPOUND COMPOSITIONS AND TWO-CYCLE ENGINE OILS AND FUELS CONTAINING SAME THE LUBRIZOL CORPORATION (US) 1986-06-05 WO disclosed
EP-0141839-A1 PHOSPHORUS-CONTAINING METAL SALTS/SULFURIZED PHENATE COMPOSITIONS/AROMATIC SUBSTITUTED TRIAZOLES, CONCENTRATES, AND FUNCTIONAL FLUIDS CONTAINING SAME. LUBRIZOL CORP (US) 1985-05-22 EP disclosed
WO-1984004322-A1 PHOSPHORUS-CONTAINING METAL SALTS/SULFURIZED PHENATE COMPOSITIONS/AROMATIC SUBSTITUTED TRIAZOLES, CONCENTRATES, AND FUNCTIONAL FLUIDS CONTAINING SAME LUBRIZOL CORP (US) 1984-11-08 WO disclosed
US-4466894-A Phosphorus-containing metal salts/sulfurized phenate compositions/aromatic substituted triazoles, concentrates, and functional fluids containing same THE LUBRIZOL CORPORATION (US) 1984-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132352-A1 LUBRICATING OIL COMPOSITIONS SFN, DGKG, TAF1 LIPG 137/4885KCNH2 1794/4885BID 2332/4885
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 PHOSPHO1, SIGMAR1, SGMS1 LIPG 581/4885KCNH2 676/4885BID 2562/4885
US-20260109910-A1 Lubricant Compositions Containing High C9 Disubstituted Diphenylamine Antioxidant Content and Low Mono- and Tri-substituted Diphenylamine Antioxidant Content C9, SOD1, TDO2 LIPG 1520/4885KCNH2 2103/4885BID 3133/4885
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 SIGMAR1, PHOSPHO1, SGMS1 LIPG 651/4885KCNH2 311/4885BID 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.